Literature DB >> 11278960

Human ClC-3 is not the swelling-activated chloride channel involved in cell volume regulation.

K H Weylandt1, M A Valverde, M Nobles, S Raguz, J S Amey, M Diaz, C Nastrucci, C F Higgins, A Sardini.   

Abstract

Volume regulation is essential for normal cell function. A key component of the cells' response to volume changes is the activation of a channel, which elicits characteristic chloride currents (I(Cl, Swell)). The molecular identity of this channel has been controversial. Most recently, ClC-3, a protein highly homologous to the ClC-4 and ClC-5 channel proteins, has been proposed as being responsible for I(Cl, Swell). Subsequently, however, other reports have suggested that ClC-3 may generate chloride currents with characteristics clearly distinct from I(Cl, Swell). Significantly different tissue distributions for ClC-3 have also been reported, and it has been suggested that two isoforms of ClC-3 may be expressed with differing functions. In this study we generated a series of cell lines expressing variants of ClC-3 to rigorously address the question of whether or not ClC-3 is responsible for I(Cl, Swell). The data demonstrate that ClC-3 is not responsible for I(Cl, Swell) and has no role in regulatory volume decrease, furthermore, ClC-3 is not activated by intracellular calcium and fails to elicit chloride currents under any conditions tested. Expression of ClC-3 was shown to be relatively tissue-specific, with high levels in the central nervous system and kidney, and in contrast to previous reports, is essentially absent from heart. This distribution is also inconsistent with the previous proposed role in cell volume regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278960     DOI: 10.1074/jbc.M011667200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Proteolytic modification of swelling-activated Cl- current in LNCaP prostate cancer epithelial cells.

Authors:  Yulia V Vitko; Nelli H Pogorelaya; Natalia Prevarskaya; Roman Skryma; Yaroslav M Shuba
Journal:  J Bioenerg Biomembr       Date:  2002-08       Impact factor: 2.945

2.  CLC-3 knockout hints at swelling-activated chloride channel complexity.

Authors:  Iain A Greenwood
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

Review 3.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

5.  Activation of swelling-activated chloride current by tumor necrosis factor-alpha requires ClC-3-dependent endosomal reactive oxygen production.

Authors:  James J Matsuda; Mohammed S Filali; Jessica G Moreland; Francis J Miller; Fred S Lamb
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

6.  The ClC-3 Cl-/H+ antiporter becomes uncoupled at low extracellular pH.

Authors:  James J Matsuda; Mohammed S Filali; Malia M Collins; Kenneth A Volk; Fred S Lamb
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

Review 7.  Diversity of Cl(-) channels.

Authors:  M Suzuki; T Morita; T Iwamoto
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

8.  ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells.

Authors:  Christa W Habela; Michelle L Olsen; Harald Sontheimer
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

Review 9.  Flufenamic acid as an ion channel modulator.

Authors:  Romain Guinamard; Christophe Simard; Christopher Del Negro
Journal:  Pharmacol Ther       Date:  2013-01-25       Impact factor: 12.310

10.  Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons.

Authors:  Ling Wei; Ai Ying Xiao; Chun Jin; Aizhen Yang; Zhong Yang Lu; Shan Ping Yu
Journal:  Pflugers Arch       Date:  2004-04-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.